We are live on ! Find out more

FPRX

Five Prime Therapeutics, Inc.

FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

63 hedge funds and large institutions have $144M invested in Five Prime Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New

Increased

Maintained

Reduced

Closed

18% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 17

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

2% more funds holding

Funds holding: 62 → 63 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

19% less capital invested

Capital invested by funds: $177M → $144M (-$33.7M)

Holders

Holders Change

Holders Change %

+1.61%

% of All Funds

1.83%

Holding in Top 10

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

0.03%

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

Rank	Fund	Capital Flow
1	Adage Capital Partners Boston, Massachusetts	+$5.21M
2	T. Rowe Price Associates Baltimore, Maryland	+$3.16M
3	Wellington Management Group Boston, Massachusetts	+$3.06M
4	BI BVF Inc San Francisco, California	+$2.64M
5	Millennium Management New York	+$1.2M

Top Sellers

Rank	Fund	Capital Flow
1	Franklin Resources San Mateo, California	-$6.82M
2	BIT BlackRock Institutional Trust San Francisco, California	-$1.09M
3	GPCM Granite Point Capital Management Boston, Massachusetts	-$622K
4	Allianz Asset Management Munich, Germany	-$550K
5	Goldman Sachs New York	-$409K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	BCM 26 Bridgeway Capital Management Houston, Texas	$692K	+$442K	+35,000	+146%
27	27 Geode Capital Management Boston, Massachusetts	$624K	-$88	-7	-0%
28	BIM 28 BlackRock Investment Management Wilmington, Delaware	$588K	+$11.7K	+924	+2%
29	NI 29 Numeric Investors Boston, Massachusetts	$540K	+$279K	+22,149	+93%
30	NFA 30 Nationwide Fund Advisors Columbus, Ohio	$429K	+$33.4K	+2,650	+8%
31	TRSOTSOK 31 Teachers Retirement System of the State of Kentucky Frankfort, Kentucky	$383K	+$73.9K	+5,860	+22%
32	32 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$372K	+$2.28K	+181	+0.6%
33	33 California Public Employees Retirement System Sacramento, California	$301K	–	–	–
34	34 Charles Schwab San Francisco, California	$297K	–	–	–
35	TA 35 Teachers Advisors New York	$281K	–	–	–
36	36 Morgan Stanley New York	$269K	+$62.3K	+4,934	+27%
37	ROTUOC 37 Regents of the University of California Oakland, California	$261K	+$280K	+22,214	New
38	BBA 38 Baker Bros. Advisors New York	$233K	–	–	–
39	TC 39 TFS Capital West Chester, Pennsylvania	$229K	-$94K	-7,452	-28%
40	40 JP Morgan Chase New York	$197K	+$212K	+16,791	New
41	MLICM 41 Metropolitan Life Insurance Company (MetLife) New York	$165K	–	–	–
42	42 RhumbLine Advisers Boston, Massachusetts	$150K	–	–	–
43	43 VOYA Investment Management Atlanta, Georgia	$149K	–	–	–
44	44 Citadel Advisors Miami, Florida	$141K	+$152K	+12,020	New
45	AIG 45 American International Group New York	$132K	-$88	-7	-0.1%
46	TAM 46 Tocqueville Asset Management New York	$132K	-$338K	-26,800	-70%
47	47 State Board of Administration of Florida Retirement System Tallahassee, Florida	$132K	–	–	–
48	48 PNC Financial Services Group Pittsburgh, Pennsylvania	$131K	–	–	–
49	49 Deutsche Bank Frankfurt Am Main Ge, Germany	$91K	+$22.9K	+1,813	+30%
50	50 Citigroup New York	$87K	-$29.9K	-2,369	-24%

FPRX Hedge Fund Activity: Q3 2014 in Review

63 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q3 2014, worth a combined $144M — down 19% from $177M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new FPRX positions and 8 closed out — a net gain of 1 holder — while 20 added to existing stakes and 17 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $5.21M. The largest seller was Franklin Resources, exiting entirely with an estimated $6.82M sold.

63 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q3 2014, up from 62 in Q2 2014.
Funds reported $144M of Five Prime Therapeutics, Inc. stock for Q3 2014, down 19% quarter-over-quarter.
9 funds opened new Five Prime Therapeutics, Inc. positions in Q3 2014 and 8 closed out, a net change of +1 holder.
The largest Five Prime Therapeutics, Inc. buyer in Q3 2014 was Adage Capital Partners, an estimated $5.21M added.
The largest Five Prime Therapeutics, Inc. seller in Q3 2014 was Franklin Resources, an estimated $6.82M sold.

Based on aggregated 13F filings for Q3 2014.

Five Prime Therapeutics, Inc. FPRX